Alcon Inc (NYSE:ALC) posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact.
The company reported adjusted earnings of 76 cents per share, beating the consensus of 72 cents. Alcon reported second-quarter sales of $2.58 billion, up 4% year over year, missing the consensus of $2.63 billion.
“Alcon is exiting the second quarter with solid momentum, despite a relatively soft surgical market in the first half of the year,” said David J. Endicott, Alcon’s Chief Executive Officer. “Robust early demand for our recent product launches, including Unity VCS, Voyager, PanOptix Pro, Precision7, Systane Pro PF, and Tryptyr, …